At @AMPath's Annual Meeting, Myriad's President & CEO, Paul Diaz, joined a panel discussion, moderated by @GeneticsJen, to reflect on the ten years since the AMP v. Myriad Supreme Court decision and shared Myriad's current perspective and vision for the future. #AMPath23
Every day HHS is working to drive innovation in health, from groundbreaking research at @ARPA_H to our work on the President’s Cancer Moonshot, and so much more.
On the 10th anniversary of AMP v. Myriad (2013), AMP reflects on how the Supreme Court’s 9-0 ruling invalidating #genepatents revolutionized the way diseases are diagnosed and contributes to improved patient outcomes. #precisionmedicine#genetictesting https://t.co/EAKJD64cxz
@CELLebrateHeLa@GeneticJen A4: We have seen a shift in the patient voice being more powerful in the consent https://t.co/oGAGSJTJTv longer will patients blindly sign up to things they are seeking more transparency in order to make sure they are treated with both dignity and respect.@CELLebrateHeLa#HELA100
A4: Consenting for research should be an active and thoughtful process,
and thanks to advocates such as the Lacks Family, today, patients have a strong voice in how their health data is used, accessed, and shared by researchers. #HELA100@CELLebrateHela
Have you RSVP'd at https://t.co/JKNj0rCSEH for #HenriettaLacks 100th Birthday CELLebration on next Saturday, August 1, 2020?! @LacksFamily is honored to announce the incredible speakers for the #HELA100 Virtual Symposium! @ruha9 @NIHDirector @CamilleSchrier @RebeccaSkloot
AMP has assembled a list of available resources on testing for #COVID-19. We will update this page as new information becomes available. https://t.co/8OpIqlfK8j
#molpath colleagues, roses are red, violets are blue, I'm with @AMPath on the Hill today, advocating for you! Thx for all you do for patient care. #HealthPolicyValentine